Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)
Rethinking Clinical Trials
NOVEMBER 1, 2022
Important issues early on included COVID-19’s effects on the workplace, vaccine access and willingness, and impact on home life. The HERO TOGETHER study leveraged the HERO Registry to estimate real-world incidence of safety events among vaccinated individuals. Russell Rothman, MD, MPP. Vanderbilt University Medical Center. Key Points.
Let's personalize your content